[HLBANK] YoY Annual (Unaudited) Result on 30-Jun-2019 [#4]

Announcement Date
28-Aug-2019
Admission Sponsor
-
Sponsor
-
Financial Year
30-Jun-2019
Quarter
30-Jun-2019 [#4]
Profit Trend
YoY- 1.0%
View:
Show?
Annual (Unaudited) Result
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
Revenue 5,597,408 5,466,873 4,778,356 4,725,835 4,839,565 4,550,649 4,177,862 4.99%
PBT 4,366,800 3,470,939 2,989,397 3,186,020 3,246,255 2,748,252 2,381,699 10.62%
Tax -1,077,517 -610,297 -494,800 -521,513 -608,177 -603,236 -478,282 14.48%
NP 3,289,283 2,860,642 2,494,597 2,664,507 2,638,078 2,145,016 1,903,417 9.54%
-
NP to SH 3,289,283 2,860,642 2,494,597 2,664,507 2,638,078 2,145,016 1,903,417 9.54%
-
Tax Rate 24.68% 17.58% 16.55% 16.37% 18.73% 21.95% 20.08% -
Total Cost 2,308,125 2,606,231 2,283,759 2,061,328 2,201,487 2,405,633 2,274,445 0.24%
-
Net Worth 31,006,211 29,461,726 27,221,136 25,472,637 23,893,507 22,684,628 19,683,995 7.86%
Dividend
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
Div 1,127,126 1,023,687 736,812 1,022,997 981,924 920,476 782,019 6.27%
Div Payout % 34.27% 35.79% 29.54% 38.39% 37.22% 42.91% 41.09% -
Equity
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
Net Worth 31,006,211 29,461,726 27,221,136 25,472,637 23,893,507 22,684,628 19,683,995 7.86%
NOSH 2,167,718 2,167,718 2,167,718 2,167,718 2,167,718 2,167,718 2,167,718 0.00%
Ratio Analysis
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
NP Margin 58.76% 52.33% 52.21% 56.38% 54.51% 47.14% 45.56% -
ROE 10.61% 9.71% 9.16% 10.46% 11.04% 9.46% 9.67% -
Per Share
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
RPS 273.13 267.02 233.47 230.98 236.58 222.47 219.04 3.74%
EPS 160.60 139.72 121.88 130.23 128.96 104.86 99.79 8.24%
DPS 55.00 50.00 36.00 50.00 48.00 45.00 41.00 5.01%
NAPS 15.13 14.39 13.30 12.45 11.68 11.09 10.32 6.58%
Adjusted Per Share Value based on latest NOSH - 2,167,718
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
RPS 273.05 266.68 233.10 230.53 236.08 221.99 203.80 4.99%
EPS 160.46 139.55 121.69 129.98 128.69 104.64 92.85 9.54%
DPS 54.98 49.94 35.94 49.90 47.90 44.90 38.15 6.27%
NAPS 15.1254 14.372 13.279 12.426 11.6557 11.066 9.6022 7.86%
Price Multiplier on Financial Quarter End Date
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
Date 30/06/22 30/06/21 30/06/20 28/06/19 29/06/18 30/06/17 30/06/16 -
Price 20.46 18.72 14.08 19.00 18.20 15.66 13.18 -
P/RPS 7.49 7.01 6.03 8.23 7.69 7.04 6.02 3.70%
P/EPS 12.75 13.40 11.55 14.59 14.11 14.93 13.21 -0.58%
EY 7.84 7.46 8.66 6.85 7.09 6.70 7.57 0.58%
DY 2.69 2.67 2.56 2.63 2.64 2.87 3.11 -2.38%
P/NAPS 1.35 1.30 1.06 1.53 1.56 1.41 1.28 0.89%
Price Multiplier on Announcement Date
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
Date 30/08/22 30/08/21 28/08/20 28/08/19 28/08/18 24/08/17 29/08/16 -
Price 20.92 19.20 14.00 16.26 20.00 15.50 13.12 -
P/RPS 7.66 7.19 6.00 7.04 8.45 6.97 5.99 4.18%
P/EPS 13.03 13.74 11.49 12.49 15.51 14.78 13.15 -0.15%
EY 7.67 7.28 8.71 8.01 6.45 6.77 7.61 0.13%
DY 2.63 2.60 2.57 3.08 2.40 2.90 3.13 -2.85%
P/NAPS 1.38 1.33 1.05 1.31 1.71 1.40 1.27 1.39%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment